0001104659-21-153182.txt : 20211223
0001104659-21-153182.hdr.sgml : 20211223
20211223165513
ACCESSION NUMBER: 0001104659-21-153182
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211214
FILED AS OF DATE: 20211223
DATE AS OF CHANGE: 20211223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Susan Laura
CENTRAL INDEX KEY: 0001901039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 211517765
MAIL ADDRESS:
STREET 1: 5 OVERLOOK CT
CITY: LAMBERTVILLE
STATE: NJ
ZIP: 08530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
4
1
tm2135463-8_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-14
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001901039
Smith Susan Laura
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE SUITE 3350
NEW YORK
NY
10169
0
1
0
0
SVP & CCO
Employee Stock Option (right to buy)
15.73
2021-12-14
4
A
0
64000
0
A
2031-12-14
Common stock
64000
64000
D
Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
The stock option shall vest and become exercisable as to 25% of the shares subject to the option on December 14, 2022, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
/s/ Susan Laura Smith
2021-12-23